So Y. Park
Yangsan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Age- and disability-based trends in potentially preventable hospitalizations: evidence from nationwide claims data in Korea.
Journal: Epidemiology and health
Published: September 09, 2025
Age- and disability-based trends in potentially preventable hospitalizations: evidence from nationwide claims data in South Korea.
Journal: Epidemiology and health
Published: September 09, 2025
Retraction: Inhibition of HMGB1-Induced Angiogenesis by Cilostazol via SIRT1 Activation in Synovial Fibroblasts from Rheumatoid Arthritis.
Journal: PloS one
Published: March 20, 2020
Focus group interview regarding the accessibility of health information for people with disabilities and means of improving this accessibility in the future.
Journal: Medicine
Published: February 22, 2020
Combination therapy with cilostazol, aripiprazole, and donepezil protects neuronal cells from β-amyloid neurotoxicity through synergistically enhanced SIRT1 expression.
Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology
Published: December 20, 2019
Korean medical students' attitudes toward academic misconduct: a cross-sectional multicenter study.
Journal: Korean journal of medical education
Published: October 14, 2019
Effect of Statin Use on Liver Cancer Mortality Considering Hypercholesterolemia and Obesity in Patients with Non-Cirrhotic Chronic Hepatitis B.
Journal: Yonsei medical journal
Published: July 03, 2019
Cilostazol add-on therapy for celecoxib synergistically inhibits proinflammatory cytokines by activating IL-10 and SOCS3 in the synovial fibroblasts of patients with rheumatoid arthritis.
Journal: Inflammopharmacology
Published: March 28, 2019
Multitarget-based cotreatment with cilostazol and celecoxib synergistically suppresses collagen-induced arthritis in mice by enhancing interleukin-10 expression.
Journal: International immunopharmacology
Published: March 19, 2019
Multitarget-directed cotreatment with cilostazol and aripiprazole for augmented neuroprotection against oxidative stress-induced toxicity in HT22 mouse hippocampal cells.
Journal: European journal of pharmacology
Published: January 28, 2019
Augmented improvement of cognition and memory by aripiprazole add-on for cilostazol treatment in the chronic cerebral hypoperfusion mouse model.
Journal: Behavioural brain research
Published: January 17, 2019
Last Updated: 09/26/2026